Oral leukoplakia and erythroplakia
Potentially malignant oral lesions · Dental & Oral
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
White (leukoplakia) or red (erythroplakia) mucosal patches that cannot be rubbed off or attributed to another condition, representing potentially malignant disorders. Erythroplakia carries a particularly high risk of dysplasia/carcinoma. They warrant prompt specialist referral and biopsy.
Red flags
- Erythroplakia (red patch) — high malignant risk
- Induration, ulceration or non-homogeneous (speckled) appearance
- Associated neck lymphadenopathy
- Rapid change in size/appearance
Assessment
Differential diagnosis
- Oral squamous cell carcinoma
- Oral lichen planus
- Frictional/factitious keratosis
- Oral candidiasis (rub-off, responds to antifungal)
- Oral hairy leukoplakia (HIV/EBV)
- Lichenoid/contact reaction
Investigations
- Oral exam — persistent white/red patch not wiping off, site and texture
- Risk factors: smoking, alcohol, betel/areca nut
- Exclude candidiasis (does it wipe off / respond to antifungal?)
- HIV status if hairy leukoplakia suspected
- Specialist incisional biopsy for histology (definitive)
- Photograph and map lesion for follow-up
Management
- Identify a persistent white/red patch that cannot be scraped off
- Remove obvious local irritants (sharp teeth, smoking, betel nut) and reassess
- Trial antifungal if candidiasis is plausible and reassess — persistence mandates referral
- Advise smoking and alcohol cessation
- Refer urgently (2-week-wait/suspected cancer pathway) to oral medicine/OMFS for biopsy
- Do not delay referral of erythroplakia — high malignant potential
- Arrange histological diagnosis and ongoing surveillance of dysplastic lesions
- Safety-net and ensure the referral is actioned
Drugs & doses
Nystatin oral suspension — 1 mL (100,000 units/mL) QDS or fluconazole 50 mg PO OD — therapeutic trial if candidiasis plausible
Smoking-cessation pharmacotherapy (e.g. nicotine replacement) — as adjunct
No specific medication cures the lesion — biopsy guides management
Disposition
Refer urgently via the suspected head and neck cancer pathway for biopsy; advise risk-factor cessation; arrange surveillance of confirmed dysplastic lesions.
Complications & pitfalls
- Progression to oral squamous cell carcinoma
- Delayed cancer diagnosis
- Field change/multiple lesions
- Recurrence after excision
Exam pearls
- A red patch (erythroplakia) is more sinister than a white one and needs urgent biopsy
- A persistent lesion that will not wipe off and is not candidiasis must be referred, not watched indefinitely
- Smoking, alcohol and betel/areca nut are the major modifiable risk factors
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.